Ira Schmid - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ira Schmid

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Biomacromolecules|July 27, 2017

Amphiphilic Polysaccharide Block Copolymers for pH-Responsive Micellar NanoparticlesBenjamin B Breitenbach, Ira Schmid, Peter R Wich

Frontiers in Pharmacology|January 6, 2025

Tenecteplase: biochemical and clot lysis activity comparisonsJan Bechmann, Ira Schmid, Simone Brand, et al.

Journal of Medicinal Chemistry|August 2, 2017

Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Biomacromolecules|July 27, 2017

Amphiphilic Polysaccharide Block Copolymers for pH-Responsive Micellar NanoparticlesBenjamin B Breitenbach, Ira Schmid, Peter R Wich

Frontiers in Pharmacology|January 6, 2025

Tenecteplase: biochemical and clot lysis activity comparisonsJan Bechmann, Ira Schmid, Simone Brand, et al.

Journal of Medicinal Chemistry|August 2, 2017

Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.

Pageof 1